Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

As a stakeholder in the health and life sciences industry, you work every day to improve human health and enhance patient care. Our national health and life sciences industry team partners with you to advance your objectives. We understand how changing business models, disruptive technologies and increased data security challenges, among other developments, impact your organization, and we work to help you overcome challenges and seize opportunities in this continuously evolving landscape. Whether we are collaborating with a pharmaceutical or medical device manufacturer to guide a new product through the development and approval life cycle or helping health care providers implement their strategic objectives, we provide business-minded solutions to address your most pressing challenges. Our team handles major strategic transactions; represents clients in high-stakes governmental investigations; negotiates cost-saving outsourcing arrangements, IP licenses, software and AI agreements, and research and collaboration agreements; and executes public policy and government affairs strategies for health care, life sciences and patient advocacy organizations. Our professionals include former in-house counsel at health systems and global pharmaceutical and device companies, former congressional and federal agency health policy specialists, and Department of Justice attorneys.

Insights & Events

Latest

Media Mentions May 2025

Kacey Dugan Discusses Impacts of Healthcare Cuts on Rideshare Apps With Modern Healthcare

1 min read  
Speaking Engagement Recap May 16, 2025

AI Policy and the New Administration: Implications for FDA-Regulated Industries

2025 FDLI Annual Conference
1 min read  
Speaking Engagement Recap May 16, 2025

Cosmetics in a Post-MoCRA World: Enforcement, Claims, and State Regulations

2025 FDLI Annual Conference
1 min read  
Updates May 2025

Is This the Death Knell of Strict Liability Crimes?

The Impact of President Trump’s May 9, 2025, Executive Order on Regulatory Criminal Offenses & FDCA Enforcement
10 min read  
Press Release May 2025

Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD

2 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Updates May 2025

HHS and FDA Launch RFI on Deregulatory Plan — A Key Opportunity to Shape Health and Food Policy

Submissions Through Regulations.gov Due July 14, 2025
4 min read  
Published Articles May 2025

The Booming Business of Botox: Legal Considerations for Medical Spas

2 min read  
Press Release May 2025

Faegre Drinker Grows Customs & International Trade Practice in Washington, D.C., Welcoming Prominent Trade Enforcement Partner Daniel Wilson

3 min read  
Recorded Webinar May 01, 2025 CLE

Inside the FDA Under Trump 2.0 — Continuing the Discussion on the New Administration’s Changes to the FDA - Webinar

1 min read  

Related Legal Services